Provention Bio, Inc

(NASDAQ:PRVB)

Latest On Provention Bio, Inc (PRVB):

Date/Time Type Description Signal Details
2023-04-27 22:14 ESTNewsSanofi completes Provention Bio acquisitionN/A
2023-04-26 21:10 ESTNewsProvention Bio gains after HSR waiting period for Sanofi deal expiredN/A
2023-03-26 11:32 ESTNewsProvention Bio: Sanofi Acquires Provention Bio With A 273% PremiumN/A
2023-03-15 15:43 ESTNewsProvention Bio Q4 2022 Earnings PreviewN/A
2023-03-13 17:55 ESTNewsProvention Bio stock rockets 260% on ~$2.9B acquisition by SanofiN/A
2023-03-13 17:54 ESTNewsHot Stocks: ZIM rises on earnings; SGEN jumps on acquisition deal; FRC, SCHW slide in SVB aftermathN/A
2023-02-22 16:46 ESTNewsProvention Bio: Good Prospects In Type 1 Diabetes, But Patent Protection Is A WorryN/A
2023-02-07 09:46 ESTNewsProvention Bio: Ability To Expand T1D Market Presence With Second Half 2023 DataN/A
2023-01-02 16:25 ESTNewsProvention Bio: Tzield Finally Approved, But Neutral On Its Commercial LaunchN/A
2022-11-25 19:34 ESTNewsProvention Bio: Assessing The Investment Case After Teplizumab ApprovalN/A
2022-11-18 19:19 ESTNewsMacroGenics to get $60M milestone from Provention as FDA approves diabetes drug TzieldN/A
2022-11-18 01:55 ESTNewsProvention Bio's type 1 diabetes med teplizumab wins FDA approvalN/A
2022-11-04 07:15 ESTNewsProvention Bio, Inc. (PRVB) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 14:16 ESTNewsProvention Bio GAAP EPS of -$0.34 beats by $0.08, revenue of $0.8M beats by $0.02MN/A
2022-11-03 14:14 ESTNewsProvention climbs 27% as FDA proposes labeling for experimental diabetes drugN/A
2022-10-26 21:50 ESTNewsProvention Bio: The Heat Is On Teplizumab For FDA ApprovalN/A
2022-10-07 20:12 ESTNewsProvention Bio continues hot streak following diabetes drug deal with SanofiN/A
2022-10-06 15:42 ESTNewsProvention stock soars 17% on pact with Sanofi for potential diabetes drug teplizumabN/A
2022-09-19 10:32 ESTNewsProvention Bio appoints O'Brien as Chief People OfficerN/A
2022-09-01 10:08 ESTNewsProvention Bio secures $125M term loan facilityN/A
2022-08-12 23:58 ESTNewsProvention Bio: More Risk, More Dilution Ahead - Downgrading To A Sell RatingN/A
2022-08-06 13:49 ESTNewsProvention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 15:41 ESTNewsProvention Bio GAAP EPS of -$0.46 beats by $0.04, revenue of $0.75M beats by $0.05MN/A
2022-08-04 00:57 ESTNewsProvention Bio Q2 2022 Earnings PreviewN/A
2022-07-12 00:11 ESTNewsHC Wainwright cuts PT on Provention Bio to reflect recent financingN/A
2022-07-08 07:50 ESTNewsProvention Bio to raise $60M through private placement of securitiesN/A
2022-07-01 09:48 ESTNewsProvention Bio says FDA extends review period for co's teplizumab application to Nov. 17N/A
2022-05-06 06:40 ESTNewsProvention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-05 08:14 ESTNewsProvention Bio Q1 2022 Earnings PreviewN/A
2022-05-05 08:13 ESTNewsProvention Bio GAAP EPS of -$0.35 beats by $0.11, revenue of $0.58M misses by $0.12MN/A
2022-04-01 11:02 ESTNewsProvention Bio (PRVB): BLA Accepted; Downgrading To A HoldN/A
2022-03-22 01:19 ESTNewsProvention Bio says FDA accepted marketing application for diabetes candidateN/A
2022-02-24 17:37 ESTNewsProvention Bio GAAP EPS of -$0.41 beats by $0.04N/A
2022-02-24 17:37 ESTNewsProvention Bio, Inc's. (PRVB) CEO Ashleigh Palmer on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 00:45 ESTNewsProvention Bio Q4 2021 Earnings PreviewN/A
2022-02-22 09:24 ESTNewsProvention Bio resubmits marketing application for diabetes drug in U.S.N/A
2022-02-05 01:43 ESTNewsProvention Bio: Upgrading To A Strong-Buy, Potential Cure For Type 1 DiabetesN/A
2022-01-31 21:41 ESTNewsProvention Bio continues surge from teplizumab BLA resubmission; shares up 28%N/A
2022-01-27 19:19 ESTNewsProvention Bio up 16% after saying it will resubmit teplizumab BLA for type 1 diabetesN/A
2022-01-21 00:03 ESTNewsProvention Bio initiates mid-stage study of lupus candidate PRV-3279N/A
2022-01-07 09:12 ESTNewsProvention Bio grants inducement options to senior VPN/A
2021-12-20 13:03 ESTNewsProvention Bio names Christina Yi as COO, Benedict Osorio Chief Quality OfficerN/A
2021-11-22 08:24 ESTNewsProvention Bio jumps 12% after providing regulatory update for teplizumabN/A
2021-11-04 14:57 ESTNewsProvention Bio EPS beats by $0.07, misses on revenueN/A
2021-11-04 14:57 ESTNewsProvention Bio names industry veteran as CFON/A
2021-11-04 14:57 ESTNewsProvention Bio, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-04 14:56 ESTNewsProvention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 17:35 ESTNewsProvention Bio Q3 2021 Earnings PreviewN/A
2021-10-27 01:37 ESTNewsProvention Bio reports positive early-stage data for coxsackievirus B vaccine candidateN/A
2021-08-07 23:36 ESTNewsProvention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q2 2021 Results - Earnings Call TranscriptN/A

About Provention Bio, Inc (PRVB):

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-6527, an oral CSF-1R inhibitor, which has completed Phase IIa clinical trial for the treatment of Crohn's disease; PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. The company was incorporated in 2016 and is headquartered in Red Bank, New Jersey.

PRVB Quotes by TradingView

See Advanced Chart

General

  • Name Provention Bio, Inc
  • Symbol PRVB
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 59
  • Fiscal Year EndDecember
  • IPO Date2018-07-24
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.proventionbio.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 8.06
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.29
  • Next Year EPS Estimate -$1.31
  • Next Quarter EPS Estimate -$0.38
  • Return on Assets -58%
  • Return on Equity -102%
  • Earnings Per Share -$0.94
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 826.41 million
  • Analyst Target Price $29.43
  • Book Value Per Share $1.97
View More

Share Statistics

  • Shares Outstanding 63.37 million
  • Shares Float 45.82 million
  • % Held by Insiders 1825%
  • % Held by Institutions 42.82%
  • Shares Short 2.8 million
  • Shares Short Prior Month 2.86 million
  • Short Ratio 3.31
  • Short % of Float 5%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 3.36
  • 52 Week High $19.19
  • 52 Week Low $6.25
  • 50 Day Moving Average 13.74
  • 200 Day Moving Average 14.49
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Provention Bio, Inc (PRVB) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Provention Bio, Inc (PRVB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.58-$0.51-14.85%
2020-09-302020-11-05$N/A-$0.56-$0.40-39.13%
2020-06-302020-08-06$N/A-$0.45-$0.27-69.17%
2020-03-312020-05-07$N/A-$0.26-$0.25-2.65%
2019-12-312020-03-12$N/A-$0.22-$0.234.35%
2019-09-302019-11-05$N/A-$0.24-$0.2918.17%
2019-06-302019-08-06$N/A-$0.32-$0.31-2.14%
2019-03-312019-05-08$N/A-$0.29-$0.20-45%
2018-12-312019-03-19$N/A-$0.15-$0.1921.05%
2018-09-302018-11-08$N/A-$0.17-$0.1910.89%

Provention Bio, Inc (PRVB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Provention Bio, Inc (PRVB) Chart:

Provention Bio, Inc (PRVB) News:

Below you will find a list of latest news for Provention Bio, Inc (PRVB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Provention Bio, Inc (PRVB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest PRVB Trades:

Date Shares Price
Jun 13, 2022 7:57 PM EST400$3.805
Jun 13, 2022 7:59 PM EST38$3.81
Jun 13, 2022 7:59 PM EST56$3.805
Jun 13, 2022 7:59 PM EST105$3.795
Jun 13, 2022 7:59 PM EST45$3.81

Provention Bio, Inc (PRVB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1695357/000149315220012316/0001493152-20-012316-index.htm
2019-08-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1695357/000000000019012108/0000000000-19-012108-index.htm
2020-07-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1695357/000000000020006440/0000000000-20-006440-index.htm
2020-08-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1695357/000000000020007892/0000000000-20-007892-index.htm
2019-01-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000090445419000077/0000904454-19-000077-index.htm
2020-01-17SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000090445420000047/0000904454-20-000047-index.htm
2019-06-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000112534519000088/0001125345-19-000088-index.htm
2020-02-20SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000114036120003712/0001140361-20-003712-index.htm
2019-09-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000119312519254048/0001193125-19-254048-index.htm
2019-12-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000119312519322584/0001193125-19-322584-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000119312520038634/0001193125-20-038634-index.htm
2020-02-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000119312520040251/0001193125-20-040251-index.htm
2018-08-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218011524/0001493152-18-011524-index.htm
2018-09-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1695357/000149315218012847/0001493152-18-012847-index.htm
2018-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315218012892/0001493152-18-012892-index.htm
2018-09-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218012923/0001493152-18-012923-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218012925/0001493152-18-012925-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315218015413/0001493152-18-015413-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1695357/000149315218015414/0001493152-18-015414-index.htm
2018-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218015651/0001493152-18-015651-index.htm
2018-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218016231/0001493152-18-016231-index.htm
2018-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218016761/0001493152-18-016761-index.htm
2018-11-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218016826/0001493152-18-016826-index.htm
2018-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218016978/0001493152-18-016978-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218017143/0001493152-18-017143-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218017874/0001493152-18-017874-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218017965/0001493152-18-017965-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218018016/0001493152-18-018016-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218018017/0001493152-18-018017-index.htm
2018-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218018087/0001493152-18-018087-index.htm
2018-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218018147/0001493152-18-018147-index.htm
2018-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218018148/0001493152-18-018148-index.htm
2018-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315218018149/0001493152-18-018149-index.htm
2019-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219000056/0001493152-19-000056-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219002085/0001493152-19-002085-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219002086/0001493152-19-002086-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219002093/0001493152-19-002093-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219003585/0001493152-19-003585-index.htm
2019-03-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1695357/000149315219003588/0001493152-19-003588-index.htm
2019-03-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219003594/0001493152-19-003594-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219004069/0001493152-19-004069-index.htm
2019-03-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219004125/0001493152-19-004125-index.htm
2019-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219004128/0001493152-19-004128-index.htm
2019-04-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219005276/0001493152-19-005276-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219006586/0001493152-19-006586-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1695357/000149315219006588/0001493152-19-006588-index.htm
2019-05-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1695357/000149315219006944/0001493152-19-006944-index.htm
2019-05-29DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1695357/000149315219008313/0001493152-19-008313-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219008381/0001493152-19-008381-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219008907/0001493152-19-008907-index.htm
2019-06-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1695357/000149315219008951/0001493152-19-008951-index.htm
2019-06-14RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009161/0001493152-19-009161-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009336/0001493152-19-009336-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009337/0001493152-19-009337-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009410/0001493152-19-009410-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009411/0001493152-19-009411-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009515/0001493152-19-009515-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009679/0001493152-19-009679-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009698/0001493152-19-009698-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009699/0001493152-19-009699-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009700/0001493152-19-009700-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009702/0001493152-19-009702-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009703/0001493152-19-009703-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009704/0001493152-19-009704-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219009706/0001493152-19-009706-index.htm
2019-08-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1695357/000149315219011566/0001493152-19-011566-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219011692/0001493152-19-011692-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1695357/000149315219011694/0001493152-19-011694-index.htm
2019-08-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1695357/000149315219011772/0001493152-19-011772-index.htm
2019-08-08424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1695357/000149315219011922/0001493152-19-011922-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219011938/0001493152-19-011938-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219011939/0001493152-19-011939-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219011940/0001493152-19-011940-index.htm
2019-09-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1695357/000149315219014277/0001493152-19-014277-index.htm
2019-09-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014319/0001493152-19-014319-index.htm
2019-09-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1695357/000149315219014320/0001493152-19-014320-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014517/0001493152-19-014517-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014570/0001493152-19-014570-index.htm
2019-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014640/0001493152-19-014640-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014764/0001493152-19-014764-index.htm
2019-09-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014765/0001493152-19-014765-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014767/0001493152-19-014767-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014772/0001493152-19-014772-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219014773/0001493152-19-014773-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219016459/0001493152-19-016459-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1695357/000149315219016460/0001493152-19-016460-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219018862/0001493152-19-018862-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219019298/0001493152-19-019298-index.htm
2019-12-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1695357/000149315219019387/0001493152-19-019387-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219019631/0001493152-19-019631-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315219019725/0001493152-19-019725-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315219019733/0001493152-19-019733-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220000362/0001493152-20-000362-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220000369/0001493152-20-000369-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220000370/0001493152-20-000370-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220002499/0001493152-20-002499-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220002500/0001493152-20-002500-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220002501/0001493152-20-002501-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220003769/0001493152-20-003769-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1695357/000149315220003770/0001493152-20-003770-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220003809/0001493152-20-003809-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220004385/0001493152-20-004385-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220004386/0001493152-20-004386-index.htm
2020-04-0810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1695357/000149315220006062/0001493152-20-006062-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220006374/0001493152-20-006374-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220007948/0001493152-20-007948-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1695357/000149315220007953/0001493152-20-007953-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220009570/0001493152-20-009570-index.htm
2020-05-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220009621/0001493152-20-009621-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220009624/0001493152-20-009624-index.htm
2020-06-04DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220010529/0001493152-20-010529-index.htm
2020-06-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1695357/000149315220010531/0001493152-20-010531-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220010999/0001493152-20-010999-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220011185/0001493152-20-011185-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1695357/000149315220011294/0001493152-20-011294-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220011331/0001493152-20-011331-index.htm
2020-06-17S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1695357/000149315220011350/0001493152-20-011350-index.htm
2020-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1695357/000149315220011383/0001493152-20-011383-index.htm
2020-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1695357/000149315220011386/0001493152-20-011386-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220011391/0001493152-20-011391-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220011723/0001493152-20-011723-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220012295/0001493152-20-012295-index.htm
2020-06-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1695357/000149315220012316/0001493152-20-012316-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013445/0001493152-20-013445-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013470/0001493152-20-013470-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013471/0001493152-20-013471-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013472/0001493152-20-013472-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013473/0001493152-20-013473-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013474/0001493152-20-013474-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013475/0001493152-20-013475-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013476/0001493152-20-013476-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013477/0001493152-20-013477-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013478/0001493152-20-013478-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220013479/0001493152-20-013479-index.htm
2020-08-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220014503/0001493152-20-014503-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220014505/0001493152-20-014505-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220014803/0001493152-20-014803-index.htm
2020-08-0610-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1695357/000149315220014805/0001493152-20-014805-index.htm
2020-08-0610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1695357/000149315220014806/0001493152-20-014806-index.htm
2020-08-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1695357/000149315220014807/0001493152-20-014807-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1695357/000149315220014808/0001493152-20-014808-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220015167/0001493152-20-015167-index.htm
2020-08-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220015169/0001493152-20-015169-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220015170/0001493152-20-015170-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220015601/0001493152-20-015601-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220016129/0001493152-20-016129-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220016236/0001493152-20-016236-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220016458/0001493152-20-016458-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220016510/0001493152-20-016510-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220017159/0001493152-20-017159-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220017180/0001493152-20-017180-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220020223/0001493152-20-020223-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1695357/000149315220020528/0001493152-20-020528-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1695357/000149315220020529/0001493152-20-020529-index.htm
2020-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1695357/000149315220020592/0001493152-20-020592-index.htm
2019-08-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1695357/999999999519001842/9999999995-19-001842-index.htm
2019-05-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1695357/999999999719005122/9999999997-19-005122-index.htm

Provention Bio, Inc (PRVB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Provention Bio, Inc (PRVB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1825%
Institutional Ownership: 4282%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-11-26ANTHONY DIGIANDOMENICODirectorBuy10,000.002.6526,500.0010,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218016761/0001493152-18-016761-index.htm
2018-11-09AVERY W CATLINDirectorBuy10,000.003.1531,500.0010,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218015651/0001493152-18-015651-index.htm
2019-06-17ANTHONY DIGIANDOMENICODirectorBuy25,000.0012.16304,000.00108,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219009336/0001493152-19-009336-index.htm
2019-06-18ANTHONY DIGIANDOMENICODirectorBuy10,000.0010.88108,800.00118,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219009410/0001493152-19-009410-index.htm
2019-06-20ANTHONY DIGIANDOMENICODirectorBuy10,000.0010.96109,600.00128,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219009515/0001493152-19-009515-index.htm
2019-08-08ANTHONY DIGIANDOMENICODirectorBuy10,000.009.0990,900.00138,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219011940/0001493152-19-011940-index.htm
2019-09-25ANTHONY DIGIANDOMENICODirectorBuy5,000.008.3941,950.00143,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219014570/0001493152-19-014570-index.htm
2019-09-26ANTHONY DIGIANDOMENICODirectorBuy5,000.008.4442,200.00148,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219014640/0001493152-19-014640-index.htm
2018-12-24AVERY W CATLINDirectorBuy5,000.001.909,500.0015,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218018016/0001493152-18-018016-index.htm
2018-11-13Andrew T DrechslerChief Financial OfficerBuy10,000.002.5025,000.0016,250.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218016231/0001493152-18-016231-index.htm
2019-09-30ANTHONY DIGIANDOMENICODirectorBuy30,000.006.83204,900.00178,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219014772/0001493152-19-014772-index.htm
2020-08-13Andrew T DrechslerChief Financial OfficerBuy1,750.0013.0122,767.5018,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220015601/0001493152-20-015601-index.htm
2020-09-02Andrew T DrechslerChief Financial OfficerBuy2,000.0011.7223,440.0020,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220017159/0001493152-20-017159-index.htm
2018-11-27ANTHONY DIGIANDOMENICODirectorBuy10,000.002.4624,600.0020,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218016826/0001493152-18-016826-index.htm
2018-12-26AVERY W CATLINDirectorBuy5,000.001.859,250.0020,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218018016/0001493152-18-018016-index.htm
2018-11-29ANTHONY DIGIANDOMENICODirectorBuy151.002.47372.9720,151.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218016978/0001493152-18-016978-index.htm
2018-11-30ANTHONY DIGIANDOMENICODirectorBuy4,849.002.4511,880.0525,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218016978/0001493152-18-016978-index.htm
2018-12-28Ashleigh PalmerPresident and CEOBuy5,000.001.738,650.002,542,500.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218018148/0001493152-18-018148-index.htm
2018-12-31Ashleigh PalmerPresident and CEOBuy825.001.581,303.502,543,325.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218018148/0001493152-18-018148-index.htm
2019-06-18Ashleigh PalmerPresident and CEOBuy4,000.0010.8343,320.002,547,325.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219009411/0001493152-19-009411-index.htm
2018-12-31Francisco LeonChief Scientific OfficerBuy10,000.001.6416,400.002,547,500.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219000056/0001493152-19-000056-index.htm
2019-08-08Francisco LeonChief Scientific OfficerBuy2,500.009.0922,725.002,550,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219011939/0001493152-19-011939-index.htm
2019-09-30Francisco LeonChief Scientific OfficerBuy1,450.007.6711,121.502,551,450.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219014773/0001493152-19-014773-index.htm
2019-12-16Francisco LeonChief Scientific OfficerBuy2,000.0011.9223,840.002,553,450.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219019298/0001493152-19-019298-index.htm
2019-08-08Ashleigh PalmerPresident and CEOBuy10,600.009.1596,990.002,557,925.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219011938/0001493152-19-011938-index.htm
2019-09-24Ashleigh PalmerPresident and CEOBuy3,000.008.3825,140.002,560,925.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219014517/0001493152-19-014517-index.htm
2019-12-20Ashleigh PalmerPresident and CEOBuy2,075.0011.3923,634.252,563,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219019631/0001493152-19-019631-index.htm
2020-03-19Francisco LeonChief Scientific OfficerBuy10,000.005.9259,200.002,563,450.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220004386/0001493152-20-004386-index.htm
2020-06-24Francisco LeonChief Scientific OfficerBuy2,000.0015.4330,862.002,565,450.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220011723/0001493152-20-011723-index.htm
2020-08-17Ashleigh PalmerPresident and CEOBuy2,800.0012.8335,924.002,565,800.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220016129/0001493152-20-016129-index.htm
2020-08-18Ashleigh PalmerPresident and CEOBuy500.0012.696,345.002,566,300.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220016236/0001493152-20-016236-index.htm
2020-08-21Francisco LeonChief Scientific OfficerBuy2,000.0013.3526,708.002,567,450.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220016510/0001493152-20-016510-index.htm
2018-12-03ANTHONY DIGIANDOMENICODirectorBuy4,442.002.4510,882.9029,442.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218017143/0001493152-18-017143-index.htm
2018-12-20ANTHONY DIGIANDOMENICODirectorBuy5,000.001.969,800.0034,442.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218017874/0001493152-18-017874-index.htm
2018-12-21ANTHONY DIGIANDOMENICODirectorBuy2,000.001.853,700.0036,442.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218017965/0001493152-18-017965-index.htm
2020-04-10Jeffrey BluestoneDirectorBuy32,246.002.3676,100.5639,571.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220006374/0001493152-20-006374-index.htm
2020-03-19Jason HoittChief Commercial OfficerBuy4,500.005.4324,435.004,500.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220004385/0001493152-20-004385-index.htm
2018-12-24ANTHONY DIGIANDOMENICODirectorBuy17,270.001.9233,158.4053,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218018017/0001493152-18-018017-index.htm
2019-12-26Eleanor RamosCMO & COOBuy2,000.0014.3428,680.0062,000.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219019733/0001493152-19-019733-index.htm
2020-08-20Eleanor RamosChief Medical OfficerBuy2,500.0013.2333,075.0064,500.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220016458/0001493152-20-016458-index.htm
2020-09-02Eleanor RamosChief Medical OfficerBuy299.0012.063,605.9464,799.00https://www.sec.gov/Archives/edgar/data/1695357/000149315220017180/0001493152-20-017180-index.htm
2019-06-17Jeffrey BluestoneDirectorSell7,300.0011.9387,089.007,325.00https://www.sec.gov/Archives/edgar/data/1695357/000149315219009337/0001493152-19-009337-index.htm
2018-12-27ANTHONY DIGIANDOMENICODirectorBuy20,000.001.9539,000.0073,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218018087/0001493152-18-018087-index.htm
2018-12-28Wayne PisanoDirectorBuy5,000.001.809,000.007,500.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218018147/0001493152-18-018147-index.htm
2018-12-28ANTHONY DIGIANDOMENICODirectorBuy10,000.001.7617,600.0083,712.00https://www.sec.gov/Archives/edgar/data/1695357/000149315218018149/0001493152-18-018149-index.htm